You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR NALMEFENE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NALMEFENE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000437 ↗ Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 4 1997-09-26 The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
NCT00000437 ↗ Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Completed The Scripps Research Institute Phase 4 1997-09-26 The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
NCT00000450 ↗ Naltrexone Maintenance Treatment of Alcoholism Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 4 1997-04-10 The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
NCT00000450 ↗ Naltrexone Maintenance Treatment of Alcoholism Completed The Scripps Research Institute Phase 4 1997-04-10 The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NALMEFENE HYDROCHLORIDE

Condition Name

Condition Name for NALMEFENE HYDROCHLORIDE
Intervention Trials
Alcohol Dependence 10
Alcoholism 3
Alcohol Use Disorder 2
Pathological Gambling 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NALMEFENE HYDROCHLORIDE
Intervention Trials
Alcoholism 15
Alcohol Drinking 5
Disease 3
Opioid-Related Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NALMEFENE HYDROCHLORIDE

Trials by Country

Trials by Country for NALMEFENE HYDROCHLORIDE
Location Trials
United States 11
France 5
Germany 4
China 3
Japan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NALMEFENE HYDROCHLORIDE
Location Trials
Connecticut 2
Florida 2
Texas 2
Maryland 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NALMEFENE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for NALMEFENE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 5
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NALMEFENE HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 21
Unknown status 3
Recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NALMEFENE HYDROCHLORIDE

Sponsor Name

Sponsor Name for NALMEFENE HYDROCHLORIDE
Sponsor Trials
H. Lundbeck A/S 9
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 4
Opiant Pharmaceuticals Inc 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NALMEFENE HYDROCHLORIDE
Sponsor Trials
Other 22
Industry 19
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.